IHI:ARCA-iShares U.S. Medical Devices (USD)

ETF | Health | NYSE Arca

Last Closing

USD 64.04

Change

-0.09 (-0.14)%

Market Cap

USD 0.98B

Volume

0.67M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict
Created with Highstock 5.0.6

Verdict

About

The investment seeks to track the investment results of the Dow Jones U.S. Select Medical Equipment Index composed of U.S. equities in the medical devices sector. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index includes medical equipment companies such as manufacturers and distributors of medical devices such as magnetic resonance imaging (MRI) scanners, prosthetics, pacemakers, X-ray machines, and other non-disposable medical devices. The fund is non-diversified.

Inception Date: 01/05/2006

Primary Benchmark: DJ US Select Medical Equip TR USD

Primary Index: MSCI ACWI NR USD

Gross Expense Ratio: 0.44%

Management Expense Ratio: 0.43 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Created with Highstock 5.0.6
Cash (0%)
NotClassified (0%)
Stock non-US (0%)
Other (0%)
Stock US (100%)
Bond (0%)
Top Holdings

N/A

Top Sectors

N/A

Created with Highstock 5.0.6
Basic Materials (0%)
Consumer Cyclicals (0%)
Financial Services (0%)
Real Estate (0%)
Communication Services (0%)
Energy (0%)
Industrials (0%)
Technology (0%)
Consumer Defensive (0%)
Healthcare (99%)
Utilities (0%)
Top Regions

N/A

Created with Highstock 5.0.6
North America (100%)
United Kingdom (0%)
Europe Developed (0%)
Europe Emerging (0%)
Africa/Middle East (0%)
Japan (0%)
Australasia (0%)
Asia Developed (0%)
Asia Emerging (0%)
Latin America (0%)

Share Volume

Relative Performance (Total Returns)

Compare
IHI VTI
  • VTI
Relative Returns (From:    To: 2025-01-29 )

Largest Industry Peers for Health

Symbol Name Mer Price(Change) Market Cap
XLV Health Care Select Sector SPDR.. 0.13 %

+0.82 (+0.56%)

USD 37.71B
FHLC Fidelity® MSCI Health Care In.. 0.08 %

+0.23 (+0.33%)

USD 2.77B
FXH First Trust Health Care AlphaD.. 0.63 %

-0.04 (-0.04%)

USD 1.05B
XHE SPDR® S&P Health Care Equipme.. 0.35 %

-0.64 (-0.69%)

USD 0.20B
IDNA iShares Genomics Immunology an.. 0.00 %

+0.11 (+0.48%)

USD 0.12B
SBIO ALPS Medical Breakthroughs ETF 0.50 %

+0.03 (+0.09%)

USD 0.09B
XHS SPDR® S&P Health Care Service.. 0.35 %

-0.98 (-0.95%)

USD 0.08B
HTEC Robo Global® Healthcare Techn.. 0.00 %

-0.37 (-1.19%)

USD 0.05B
BBP Virtus LifeSci Biotech Product.. 0.79 %

+0.06 (+0.10%)

USD 0.02B
BBC Virtus LifeSci Biotech Clinica.. 0.79 %

-0.06 (-0.26%)

USD 6.89M

ETFs Containing IHI

MSSS Northern Lights Fund Trus.. 10.03 % 0.00 %

-0.09 (-0.31%)

USD 0.11B
ETAC:CA 0.00 % 1.76 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.75% 90% A- 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.75% 90% A- 91% A-
Trailing 12 Months  
Capital Gain 14.71% 90% A- 65% D
Dividend Return 0.49% 38% F 5% F
Total Return 15.19% 90% A- 60% D-
Trailing 5 Years  
Capital Gain 45.22% 86% B+ 68% D+
Dividend Return 2.48% 47% F 7% C-
Total Return 47.69% 76% C+ 63% D
Average Annual (5 Year Horizon)  
Capital Gain 3.23% 43% F 44% F
Dividend Return 3.64% 43% F 38% F
Total Return 0.41% 47% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 23.53% 38% F 47% F
Risk Adjusted Return 15.48% 43% F 31% F
Market Capitalization 0.98B N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.